Join us on 16th - 17th June online to master the art of crafting Standard Operating Procedures (SOPs) within regulated environments.
More information
RQA membership is a great way to connect with your QA colleagues.
More information
Join the community - networking, discussion and more. Open to all.
More information
Could you write an interesting article for the RQA community?
More informationICH M11 guideline, clinical study protocol template and technical specifications - Scientific guideline
Information on the new regulations for decentralised manufacture, including point of care and modular manufacture, which come into effect on 23 July 2025.
Updated Feb 2025
The GMP / GDP Inspectors Working Group extended the validity of GDP certificates as a temporary regulatory flexibility in 2021. The working group prolonged this extension until the end of 2024. From 2025, this extension no longer applies.
The 20th edition of the Veterinary Medicines newsletter.
MHRA consultation on statutory fees: proposals on ongoing cost recovery The MHRA held a public consultation on proposed amendments to its statutory fees. The consultation ran between 29 August 2024 and 24 October 2024 and was held jointly with the Department of Health in Northern Ireland, in accordance with Section 45(1) of the Medicines and Medical Devices Act 2021. This document summarises the responses to the consultation and outlines our response to feedback and proposed next steps.
In a UK-first, the Medicines and Healthcare products Regulatory Agency (MHRA) and Barts Health NHS Trust have developed a DNA sequencing approach that can be implemented onsite in hospitals so they can diagnose bacterial infections faster and more accurately.
The next MHRA Board Meeting held in public will be conducted virtually by webinar.
Following an extensive recruitment process, Mr Tallon will begin the role from 1 April 2025.
This regular CTIS newsflash provides key updates on CTIS and links to useful reference materials.